Merck & Co. Inc. (MRK)
NYSE: MRK
· Real-Time Price · USD
80.76
-0.95 (-1.16%)
At close: Jun 16, 2025, 2:16 PM
-1.16% (1D)
Bid | 80.75 |
Market Cap | 202.79B |
Revenue (ttm) | 63.92B |
Net Income (ttm) | 17.43B |
EPS (ttm) | 7.05 |
PE Ratio (ttm) | 11.46 |
Forward PE | 8.41 |
Analyst | Hold |
Ask | 80.76 |
Volume | 6,274,284 |
Avg. Volume (20D) | 16,167,561 |
Open | 80.88 |
Previous Close | 81.71 |
Day's Range | 79.71 - 81.35 |
52-Week Range | 73.31 - 134.63 |
Beta | 0.44 |
Analyst Forecast
According to 0 analyst ratings, the average rating for MRK stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-4.72%
Merck shares are trading lower. The company highli...
Unlock content with
Pro Subscription
2 months ago
-4.81%
Merck & Company shares are trading lower. The company announced it entered into an exclusive license agreement with Jiangsu Hengrui Pharmaceuticals for HRS-5346.